Brief: Biotalys Achieves Progress In Manufacturing Capabilities For Evoca
26/01/2023 06:04
Jan 26 (Reuters) - Biotalys NV BTLS.BR :
* ACHIEVES SIGNIFICANT PROGRESS IN MANUFACTURING
CAPABILITIES FOR
EVOCA
* BIOTALYS' SCIENTISTS DEVELOPED MULTIPLE PROPRIETARY YEAST
STRAINS INCREASING PRODUCTION EFFICIENCY OF BIOACTIVE INGREDIENT
OF EVOCA BY 50 TO 70% IN ONE YEAR
Source text for Eikon: ID:nGNE6LF9xn
Further company coverage: BTLS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biotalys NV
See all newsBrief: Biotalys Says EPA Files Decision To Approve Evoca Biofungicide
Brief: Biotalys Appoints Luc Van Fraeyenhoven As Chief Financial Officer
Brief: Ackermans & Van Haaren Invests Additional 5 Million Euros In Biotalys
Brief: Biotalys, Novonesis Enter Into An Agreement
Brief: Biotalys Enters Into Academic Collaborations In Europe And U.S.